Welcome to our dedicated page for FMC SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corporation has approved Project Foundation, a broad restructuring and manufacturing optimization program intended to lower costs and streamline its operations.
The company expects these actions to deliver $175 million or more of annual run-rate savings by the end of 2027. To implement the program, FMC plans to incur $560 to $635 million in pre-tax restructuring charges, including $420 to $440 million of non-cash asset write-offs and accelerated depreciation, and $140 to $195 million of cash costs such as $50 to $80 million of severance, $10 to $20 million of consulting fees, and $80 to $95 million of decommissioning and contract termination charges.
Following a significant decline in its stock price, FMC is required to test goodwill and other intangible assets for impairment for the year ending December 31, 2025 and, absent a stock price recovery, expects to record a significant non-cash impairment, which it states will not affect cash flows from current or future operations.
FMC Corporation entered into Amendment No. 5 to its Fifth Amended and Restated Credit Agreement with Citibank and other lenders. The amendment adjusts the leverage ratio and minimum interest coverage covenants during a covenant relief period that now runs until the earlier of December 31, 2028 or an elected early termination. During this period, subsidiary indebtedness is capped at an aggregate outstanding principal amount of $350 million, subject to exceptions.
The amendment also restricts increases to FMC’s regular quarterly dividend above $0.08 per share and limits any other dividends unless FMC meets a pro forma leverage ratio of no more than 3.75 to 1:00. In addition, FMC must maintain at least $1 billion in the aggregate value of specified qualifying intellectual property, and it will be required to grant a lien over substantially all of its assets if it receives public debt ratings from any two of S&P, Fitch or Moody’s below BB+ (S&P, Fitch) or Ba1 (Moody’s).
FMC Corporation reported that Anthony DiSilvestro resigned from its Board of Directors and all related committees, effective immediately on December 3, 2025. He left the Board because of increased professional commitments following his appointment as Chief Financial Officer of Keurig Dr Pepper Inc. on November 25, 2025, and related scheduling conflicts with FMC Board and committee meetings. FMC expressed appreciation for his service and contributions as a Board member.
FMC Corporation (FMC) reported an insider stock purchase by a director. On 11/13/2025, the reporting person bought 7,000 shares of common stock at $13.77 per share, coded “P” for a purchase.
Following the transaction, the reporting person beneficially owned 13,784 shares, held as Direct (D) ownership. This filing was submitted under Form 4 and signed by an attorney-in-fact on 11/14/2025.
FMC Corporation (FMC) — Form 4 insider transaction: Director Carol Anthony Davidson reported a market purchase of common stock. On 11/05/2025, she bought 10,000 shares (Transaction Code P) at an average price of $13.5957 per share. Following this trade, she directly owns 23,227 shares.
This filing reflects a personal share purchase by a board member and updates her direct beneficial ownership.
FMC Corporation reported a sharp downturn for Q3 2025. Net loss attributable to stockholders was $569.3 million on revenue of $542.2 million, compared with $65.0 million profit on $1,065.4 million revenue a year ago. Results were driven by actions to prepare the India commercial business for sale.
The India plan triggered approximately $510 million in total adjustments, including $419 million of revenue charges and a $226.8 million asset impairment, partially offset by a $144 million credit to cost of sales. Assets held for sale were $826.5 million; net assets were $450.0 million.
Year-to-date operating cash flow was $(663.3) million. Debt activity included issuing $750 million 8.45% Subordinated Notes and redeeming $500 million of 2026 senior notes; commercial paper rose to $981.8 million. Leverage was 4.94 versus a 5.25 maximum, and interest coverage was 3.93 versus a 3.00 minimum; the company was in covenant compliance. Common shares outstanding were 124,920,067 as of September 30, 2025.
FMC Corporation reported a leadership change, announcing that President Ronaldo Pereira will depart effective December 15, 2025. Pereira has served in various roles at FMC since 1995 and became President in 2024.
The company also furnished a press release on October 29, 2025 as Exhibit 99.1. The disclosure under Regulation FD is being furnished, not filed, under the Exchange Act.
FMC Corporation filed a current report to note that it has released financial results for the three months ended September 30, 2025. The company announced these quarterly results in a press release dated October 29, 2025, which is included as Exhibit 99.1 to the report.
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported two dispositions of common stock on 09/29/2025. She sold 3,790 shares at $34.00 and 5,177 shares at $33.64, reducing her direct beneficial ownership to 27,867 shares after the transactions. The filing notes the 3,790-share sale executed automatically under a Rule 10b5-1 trading plan adopted May 16, 2025. The Form 4 was signed by an attorney-in-fact on 09/30/2025.
Form 144 notice for FMC (FMC) reports a proposed sale of 3,790 common shares through Fidelity Brokerage Services with an aggregate market value of $128,860, with an approximate sale date of 09/29/2025. The shares were acquired on 09/27/2025 by restricted stock vesting from the issuer and the payment type is listed as compensation. The filing also discloses a prior sale by Jacqueline D. Scanlan of 1,510 shares on 08/18/2025 for gross proceeds of $56,609.90. The notice includes the mandatory representation that the seller does not possess undisclosed material adverse information about the issuer.